|
Volumn 32, Issue 3, 1998, Pages 187-190
|
Primary pulmonary hypertension
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCHOLINE;
ACETYLSALICYLIC ACID;
ADENOSINE;
AMINOREX;
ANOREXIGENIC AGENT;
ANTICOAGULANT AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DEXFENFLURAMINE;
DIPYRIDAMOLE;
ENDOTHELIN;
FENFLURAMINE;
NITRIC OXIDE;
PHENTERMINE;
POTASSIUM CHANNEL;
PROSTACYCLIN;
SEROTONIN;
THROMBOXANE;
VASODILATOR AGENT;
WARFARIN;
BLEEDING;
BLOOD CLOTTING DISORDER;
DRUG MECHANISM;
DRUG TOLERANCE;
EDITORIAL;
FEMALE;
GENETIC PREDISPOSITION;
HEART FAILURE;
HEART LUNG TRANSPLANTATION;
HEART SURGERY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG ARTERY PRESSURE;
LUNG BLOOD VESSEL;
MORBIDITY;
ORAL DRUG ADMINISTRATION;
OXYGEN THERAPY;
PAIN;
PATHOGENESIS;
PULMONARY HYPERTENSION;
SEROTONINERGIC SYSTEM;
SYNCOPE;
THROMBOSIS;
VALVULAR HEART DISEASE;
VASCULAR ENDOTHELIUM;
VASOCONSTRICTION;
ADULT;
ANTIHYPERTENSIVE AGENTS;
APPETITE DEPRESSANTS;
CALCIUM CHANNEL BLOCKERS;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS;
EPOPROSTENOL;
FEMALE;
FENFLURAMINE;
HUMANS;
HYPERTENSION, PULMONARY;
LUNG TRANSPLANTATION;
MULTICENTER STUDIES;
OXYGEN INHALATION THERAPY;
VASODILATOR AGENTS;
|
EID: 0031860556
PISSN: 00358819
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (6)
|
References (33)
|